Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Koup

Showing results (1-10 of 346) with videos related to

Pageof 35
Sort By:
Plos Medicine|December 4, 2004
Reconsidering early HIV treatment and supervised treatment interruptionsRichard A Koup
Annual Review of Medicine|October 15, 2017
New-Generation High-Potency and Designer Antibodies: Role in HIV-1 TreatmentLucio Gama, Richard A Koup
Trends in Immunology|March 9, 2012
Pathogen-specific T cell depletion and reactivation of opportunistic pathogens in HIV infectionChristof Geldmacher, Richard A Koup
Journal of Immunological Methods|March 1, 2003
Optimized determination of T cell epitope responsesMario Roederer, Richard A Koup
Nature Medicine|August 3, 2004
Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should knowGiuseppe Pantaleo, Richard A Koup
Current Opinion in HIV and AIDS|March 28, 2014
T follicular helper cells and HIV/SIV-specific antibody responsesConstantinos Petrovas, Richard A Koup
Methods in Cell Biology|December 18, 2004
Detection of T-cell degranulation: CD107a and bMichael R Betts, Richard A Koup
Cold Spring Harbor Perspectives in Medicine|January 10, 2012
Vaccine design for CD8 T lymphocyte responsesRichard A Koup, Daniel C Douek
AIDS (London, England)|March 24, 2012
CD8(+) T cells in preventing HIV infection and diseaseAdrian B McDermott, Richard A Koup
Cell|November 19, 2013
T cell susceptibility to HIV influences outcome of opportunistic infectionsKapil K Saharia, Richard A Koup
Pageof 35

Showing results (1-10 of 346) with videos related to

Sort By:
Pageof 35
Plos Medicine|December 4, 2004
Reconsidering early HIV treatment and supervised treatment interruptionsRichard A Koup
Annual Review of Medicine|October 15, 2017
New-Generation High-Potency and Designer Antibodies: Role in HIV-1 TreatmentLucio Gama, Richard A Koup
Trends in Immunology|March 9, 2012
Pathogen-specific T cell depletion and reactivation of opportunistic pathogens in HIV infectionChristof Geldmacher, Richard A Koup
Journal of Immunological Methods|March 1, 2003
Optimized determination of T cell epitope responsesMario Roederer, Richard A Koup
Nature Medicine|August 3, 2004
Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should knowGiuseppe Pantaleo, Richard A Koup
Current Opinion in HIV and AIDS|March 28, 2014
T follicular helper cells and HIV/SIV-specific antibody responsesConstantinos Petrovas, Richard A Koup
Methods in Cell Biology|December 18, 2004
Detection of T-cell degranulation: CD107a and bMichael R Betts, Richard A Koup
Cold Spring Harbor Perspectives in Medicine|January 10, 2012
Vaccine design for CD8 T lymphocyte responsesRichard A Koup, Daniel C Douek
AIDS (London, England)|March 24, 2012
CD8(+) T cells in preventing HIV infection and diseaseAdrian B McDermott, Richard A Koup
Cell|November 19, 2013
T cell susceptibility to HIV influences outcome of opportunistic infectionsKapil K Saharia, Richard A Koup
Pageof 35